Vascade VCS Provides Temporary Hemostasis During Vascular Closure

 

February 7, 2013
Cardiva Medical FDA Pre Market Approval Vascade VCS

Cardiva Medical's Vascade Vascular Closure System (VCS), an extravascular closure device, utilizes a unique delivery system based on a proprietary collapsible disc technology that provides temporary hemostasis during vascular closure, which eliminates the need for an intra-vascular component. Secure and rapid hemostasis is achieved with Vascade by the deployment of a thrombogenic resorbable collagen patch at the arteriotomy of the femoral artery.

The sytem received FDA PMA in February 2013

For more information: www.cardivamedical.com

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.